ROLLA, SIMONA

ROLLA, SIMONA  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 73 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice 2005 LO IACONO M; CAVALLO F; QUAGLINO E; ROLLA S; IEZZI M; PUPA SM; DE GIOVANNI C; LOLLINI PL; MUSIANI P; FORNI G; CALOGERO RA
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 2011 Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View 2019 Maglione, Alessandro; Rolla, Simona; Mercanti, Stefania Federica De; Cutrupi, Santina; Clerico, Marinella
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity 2017 Alchera, E;Rolla, S; Imarisio, C; Bardina, V; Valente, G; Novelli, F; Carini, R
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months 2016 Durelli, L; De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Annovazzi, P; Horakova, D; Novelli, F; Clerico, M
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation 2016 Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months 2016 De Mercanti, Stefania; Rolla, Simona; Cucci, Angele; Bardina, Valentina; Cocco, Eleonora; Vladic, Anton; Soldo-Butkovic, Silva; Habek, Mario; Adamec, Ivan; Horakova, Dana; Annovazzi, Pietro; Novelli, Francesco; Durelli, Luca; Clerico, Marinella
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials 2012 De Mercanti, S.; Cucci, A.; Viglietti,E.; Giai Via,A.; Taverna, D.; Cimino,D.;Rolla, S.; Bardina,V.; Novelli, F.; Vargas,J.; Gibbin,M.; Piazza,F.; Vladic,A.; Brina.V.; Habek,M.; Cocco,E.; Annavazzi,P.; Horakova,D.; Clerico, M.; Durelli, L.
Alterations in gut microbiome are associated with the onset of multiple sclerosis: an Italian pivotal study 2018 Rolla, S; Bardina, V; Ferrocino, I; De Mercanti, S; Via, AG; Lamberti, A; Lanzillo, R; Bonavita, S; Esposito, S; Giordano, M; Cocolin, LS; Clerico, M
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice 2016 Rolla, Simona; Alchera, Elisa; Imarisio, Chiara; Bardina, Valentina; Valente, Guido; Cappello, Paola; Mombello, Cristina; Follenzi, Antonia; Novelli, Francesco; Carini, Rita
can the increase of T-helper 17 Lymphocyte percentage in peripheral blood anticipate a relapse in relapsing remitting multiple sclerosis? 2010 Luca Durelli; Marinella Clerico; Simona Rolla; Giulia Contessa; Stefania De Mercanti; Antoni Uccelli; Mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; Roberto Cavallo; Luisa Sosso; Francesco Novelli
CHARACTERIZATION OF AUTOREACTIVE TCR REPERTOIRE IN PATIENTS AFFECTED BYMULTIPLE SCLEROSIS. 2011 Simona Rolla; Gabriele Di Sante; Marinella Clerico; Chiara Nicolò; Agata Katia Patanella; Antonio Amoroso; Maria Edvige Fasano; Anna Paola Batocchi; Francesco Ria; Francesco Novelli
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 2014 Occhipinti S; Sponton L; Rolla S; Caorsi C; Novarino A; Donadio M; Bustreo S; Satolli MA; Pecchioni C; Marchini C; Amici A; Cavallo F; Cappello P; Pierobon D; Novelli F; Giovarelli M.
Chromatin remodeling in Th17 and Treg plasticity induced by E2 immunomodulation 2017 Iannello A., Ferrero G., Maglione A., Cordero F., Rolla S., Bardina V., De Mercanti S., Durelli L., Clerico M., Cutrupi S.
Circulating T helper 22 cells increase in multiple sclerosis patients:phenotypical and functional characterization. 2011 Simona Rolla ; Marinella Clerico; Valentina Bardina; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
Computational modeling of the immune response in multiple sclerosis using epimod framework 2020 Pernice S.; Follia L.; Maglione A.; Pennisi M.; Pappalardo F.; Novelli F.; Clerico M.; Beccuti M.; Cordero F.; Rolla S.
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions 2004 QUAGLINO E; ROLLA S; IEZZI M; SPADARO M; MUSIANI P; DE GIOVANNI C; LOLLINI PL; LANZARDO S; FORNI G; SANGES R; CRISPI S; DE LUCA P; CALOGERO R; CAVALLO F.
D-dimer Increasing After First Alemtuzumab Administration in a Multiple Sclerosis Patient 2019 Stefania Federica De Mercanti*, Simona Rolla, Manuela Matta, Marco Iudicello, Emanuele Franchin, Marinella Clerico
Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice 2006 ROLLA S; NICOLO' C; MALINARICH S; ORSINI M; FORNI G; CAVALLO F; RIA F
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. 2011 Paola Cappello; Simona Rolla; Roberta Curto; Helen Carnevale; Roberto Chiarle; Federica Cavallo; Mirella Giovarelli; Francesco Novelli